Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
Urology|February 22, 2001
Quality of life and psychological adaptation after surgical treatment for localized renal cell carcinoma: impact of the amount of remaining renal tissueP E Clark, L R Schover, R G Uzzo, et al.Vox Sanguinis|January 1, 1975
Study of the Gregory blood group in an English familyM J Clark, J Poole, R M Barnes, et al.Toxicology and Applied Pharmacology|December 1, 1986
The distribution of [14C]acrylamide in male and pregnant Swiss-Webster mice studied by whole-body autoradiographyC Marlowe, M J Clark, R W Mast, et al.Prehospital and Disaster Medicine|March 21, 2000
Predictors of demand for emergency prehospital care: an Australian studyM J Clark, J Purdie, G J FitzGerald, et al.Journal of American College Health : J of ACH|June 16, 1999
The effects of an intervention campaign to enhance seat belt use on campusM J Clark, S Schmitz, A Conrad, et al.Bioorganic & Medicinal Chemistry|June 30, 2014
Pyrrolo- and pyridomorphinans: non-selective opioid antagonists and delta opioid agonists/mu opioid partial agonistsV Kumar, M J Clark, J R Traynor, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1994
Specificity of bone morphogenetic protein-related factors: cell fate and gene expression changes in Drosophila embryos induced by decapentaplegic but not 60AK Staehling-Hampton, P D Jackson, M J Clark, et al.Cancer Treatment Reports|June 1, 1985
Phase I study of bisantrene in acute nonlymphoblastic leukemiaM Marty, C Ferme, C Gisselbrecht, et al.Experimental Brain Research|August 11, 2001
Guiding contact by coupling the taus of gapsD N Lee, A P Georgopoulos, M J Clark, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1996
Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptorP J Emmerson, M J Clark, A Mansour, et al.Pageof 9